カリフォルニア州における横紋筋肉腫の臨床試験
カリフォルニア州内の拠点で、横紋筋肉腫に関する7件の研究が参加者を募集しています。
公式研究テキスト（英語）
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- UCSF Benioff Children's Hospital, San Francisco
被験者募集中第1相
24 Months – 18 Years · 全性別 · 2026/09/25更新 · NCT06441331Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- UCSF Benioff Children's Hospital Oakland, Oakland
- Rady Children's Hospital, San Diego
被験者募集中第1/2相
30歳以下 · 全性別 · 2026/09/03更新 · NCT06541262A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- City of Hope Comprehensive Cancer Center, Duarte
- Loma Linda University Medical Center, Loma Linda
- Cedars-Sinai Medical Center, Los Angeles
- 他4件
被験者募集中第3相
50歳以下 · 全性別 · 2026/08/25更新 · NCT07466316Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/07/31更新 · NCT07628634PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Cedars-Sinai Medical Center, Los Angeles
- University of California, San Francisco, San Francisco
被験者募集中第1/2相
1歳〜30歳 · 全性別 · 2026/07/22更新 · NCT06721689Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
- Stanford University, Palo Alto
被験者募集中第2相
22歳以下 · 全性別 · 2026/06/15更新 · NCT06023641Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Lucille Packard Children's Hospital Stanford, Palo Alto
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/05/19更新 · NCT04901702ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。